Pacemaker-induced Staphylococcus aureus mitral valve acute bacterial endocarditis complicated by persistent bacteremia from a coronary stent: Cure with prolonged/high-dose daptomycin without toxicity

Heart and Lung: Journal of Acute and Critical Care

Volumn 35, Issue 3, 2006, Pages 207-211

  Cunha, Burke A ^a,b   Eisenstein, Lawrence E ^a,b   Hamid, Naveed S ^a,b  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; CREATINE KINASE; DAPTOMYCIN; GENTAMICIN; LINEZOLID; NAFCILLIN;

ABSENCE OF SIDE EFFECTS; ADULT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL HEART PACEMAKER; BACTEREMIA; BACTERIAL ENDOCARDITIS; BLOOD CULTURE; CASE REPORT; CORONARY STENT; CREATINE KINASE BLOOD LEVEL; DEVICE INFECTION; DEVICE REMOVAL; DRUG MEGADOSE; DRUG SUBSTITUTION; ERADICATION THERAPY; HEART ABSCESS; HUMAN; LIVER TOXICITY; LONG TERM CARE; MALE; MITRAL VALVE; MITRAL VALVE DISEASE; MYALGIA; NEPHROTOXICITY; PERSISTENT INFECTION; PRIORITY JOURNAL; SHORT COURSE THERAPY; STAPHYLOCOCCUS INFECTION; TREATMENT OUTCOME;

AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; CORONARY DISEASE; DAPTOMYCIN; ECHOCARDIOGRAPHY; ENDOCARDITIS, BACTERIAL; HEART VALVE DISEASES; HUMANS; MALE; METHICILLIN RESISTANCE; MITRAL VALVE; PACEMAKER, ARTIFICIAL; PROSTHESIS-RELATED INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STENTS;

EID: 33646387421     PISSN: 01479563     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrtlng.2005.09.010     Document Type: Article

References (36)

1. In: Weinstein L., and Brusch J. (Eds). Infective Endocarditis (1996), Oxford University Press, Oxford, UK
2. Cunha B.A., Gill M.V., and Lazar J. Acute infective endocarditis. Infect Dis Clin North Am 10 (1996) 811-834
3. Chambers H.F., Korzeniowski O.M., and Sande M.A. Staphylococcus aureus Endocarditis. clinical manifestations in addicts and non-addicts. Medicine 3 (1983) 170-176
4. Giamarellou H. Nosocomial cardiac infections. J Hosp Infect 50 (2002) 91-105
5. Gilleece A., and Fenelon L. Nosocomial infective endocarditis. J Hosp Infect 46 (2000) 83-88
6. Brusch J.L. Nosocomial infective endocarditis. Infect Dis Pract 27 (2003) 247-250
7. Haddad S.H., Arabi Y.M., Memish Z.A., and Al-Shimemeri A.A. Nosocomial infective endocarditis in critically ill patients. a report of three cases and review of the literature. Int J Infect Dis 8 (2004) 210-216
8. Waldwogel F. Pacemaker infections. In: Bisno A.L., and Waldvogel F.A. (Eds). Infections Associated With Indwelling Mechanical Devices. 2nd ed. (1994), ASM Press, Washington, DC 251-258
9. Klug D., Lacroix D., Savoye C., Goullard L., Grandmougin D., Hennequin J.L., et al. Systemic infection related to endocarditis on pacemaker leads. Clinical presentation and management. Circulation 95 (1997) 2098-2107
10. Lewis A.B., Hayes D.H., Holmes Jr. D.R., et al. Update on infections involving permanent pacemakers. characterization and management. J Thorac Cardiovasc Surg 89 (1985) 758-763
11. Cacoub P., Leprince P., Nataf P., et al. Pacemaker infective endocarditis. Am J Cardiol 82 (1998) 480-484
12. Arber N., Pras E., Copperman Y., et al. Pacemaker endocarditis. Report of 44 cases and review of the literature. Medicine 73 (1994) 299-305
13. Camus C., Leport C., Raffi F., et al. Sustained bacteremia in 26 patients with a permanent endocardial pacemaker. assessment of wire removal. Clin Infect Dis 17 (1993) 46-55
14. Spinler S.A., Navarskas J.J., Foote E.F., et al. Clinical presentation and analysis of risk factors for infectious complications of implantable cardioverter-defibrillator implantations at a university medical center. Clin Infect Dis 26 (1998) 1111-1116
15. Sullenberger A.L., Avedissian L.S., and Kent S.M. Importance of transesophageal echocardiography in the evaluation of Staphylococcus aureus bacteremia. J Heart Valve Dis 14 (2005) 23-28
16. Leroy O., Martin E., Prat A., et al. Fatal infection of coronary stent implantation. Cathet Cardiovasc Diagn 39 (1996) 168-170
17. James E., Broadhurst P., Simpson A., and Das S. Bacteraemia complicating coronary artery stenting. J Hosp Infect 38 (1998) 154-155
18. Rensing B.J., van Geuns R.J., Janssen M., et al. Stentocarditis. Circulation 101 (2000) E188-E190
19. Dieter R.S. Coronary artery stent infection. Clin Cardiol 23 (2000) 808-810
20. Culver D.A., Chua J., Rehm S.J., et al. Arterial infection and Staphylococcus aureus bacteremia after transfemoral cannulation for percutaneous carotid angioplasty and stenting. J Vasc Surg 35 (2002) 576-579
21. Liu J.C., Cziperle D.J., Kleinman B., and Loeb H. Coronary abscess. a complication of stenting. Cathet Cardiovasc Interv 58 (2003) 72
22. Antonios V.S., and Baddour L.M. Intra-arterial device infections. Curr Infect Dis Rep 6 (2004) 263-269
23. Hoffman M., Baruch R., Kaplan E., et al. Coronary stent bacterial infection with multiple organ septic emboli. Eur J Intern Med 16 (2005) 123-125
24. Cunha B.A., and Ortega A. Antibiotic failure. Med Clin North Am 79 (1995) 663-672
25. Cunha B.A. Persistent Staphylococcus aureus bacteremia. a clinical approach. Infect Dis Pract 29 (2005) 444-446
26. Jeu L., and Fung H.B. Daptomycin. a cyclic lipopeptide antimicrobial agent. Clin Ther 26 (2004) 1728-1757
27. Pryka R.D., Novak R.M., Wagner D.K., and Rodvold K.A. Clinical pharmacokinetics of daptomycin. DICP 24 (1990) 255-256
28. Safdar N., Andes D., and Craig W.A. In vivo pharmacodynamic activity of daptomycin. Antimicrob Agents Chemother 48 (2004) 63-68
29. Dvorchik B.H., Brazier D., DeBruin M.F., and Arbeit R.D. Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects. Antimicrob Agents Chemother 47 (2003) 1318-1323
30. Dvorchik B., Arbeit R.D., Chung J., et al. Population pharmacokinetics of daptomycin. Antimicrob Agents Chemother 48 (2004) 2799-2807
31. Cunha B.A., Hamid H.S., Kessler H., and Parchuri S. Daptomycin cure after Cefazolin treatment failure of Staphylococcus aureus (MSSA) tricuspid valve acute bacterial endocarditis from a peripherally inserted central catheter (PICC) line. Heart Lung 34 (2005) 442-447
32. Cunha B.A. Antibiotic Essentials (2005), Physicians' Press, Royal Oak, MI
33. Sakoulas G., Eliopoulos G.M., Alder J., and Eliopoulos C.T. Efficacy of daptomycin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 47 (2003) 1714-1718
34. Cubist Pharmaceuticals. Daptomycin Package Insert (2004), Cubist Pharmaceuticals, Lexington, MA
35. Dvorchik B. Moderate liver impairment has no influence on daptomycin pharmacokinetics. J Clin Pharmacol 44 (2004) 715-722
36. Veliglandla S.R., Louie K.R., Maleskar M.A., and Smith P.W. Muscle pain associated with daptomycin. Ann Pharmacother 38 (2004) 1860-1862